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a b s t r a c t
Background: In this prospective study we evaluated the effects of treadmill training on patients’ walk-
ing ability, as well as endothelial function, high-sensitivity C-reactive protein (hs-CRP), and ﬁbrinogen
concentration.
Methods: A total of 67 patients with stable intermittent claudication were included in a 12-week super-
vised training program. An observational follow-up period then lasted a mean of 37 weeks. Forty patients
completed follow-up. Changes in blood pressure, ﬂow-mediated dilatation (FMD), and treadmill walking
performance expressed as maximal walking time (MWT) were assessed before and after the training
program and during the follow-up period. Moreover, ankle/brachial index (ABI), plasma levels of hs-CRP,
ﬁbrinogen, as well as a lipid proﬁle were assessed before and after the training program.
Results: Maximal walking time improved signiﬁcantly after treadmill training by 90% (p<0.001) and after
follow-up by 64% (p<0.001) in comparison to baseline. FMD values increased by 43% (p<0.001) after the
training program, and by 29% (p=0.058) after follow-up, compared to baseline. We noticed a signiﬁcant
decrease in hs-CRP concentration (p=0.025) and an increase in ABI values (p=0.039) in response to the
treadmill training program. No effect on lipid proﬁle was observed.
Conclusions: The 12-week treadmill training program prolonged the asymptomatic walking distance. The
improvement in FMD indicates a systemic effect of the treadmill program on endothelial function. The
supervised treadmill training provides an effective and safe treatment option in patients with PAD. The
effects of unsupervised exercise during follow-up period after treadmill programs remain tentative and
underestimated.
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ntermittent claudication
Intermittent claudication is the main symptom of peripheral
rterial disease (PAD). It is usually deﬁned as pain or muscle dis-
omfort in the lower limb induced by exercise and relieved by
est [1]. The degree of atherosclerosis and its precise localization
etermine the character and severity of claudication. Patients with
eripheral atherosclerosis, especially symptomatic patients with
ntermittent claudication demonstrate endothelial dysfunction [2].
∗ Corresponding author at: Department of Internal Medicine, University School of
edicine, Skawin´ska 8, 31-066 Cracow, Poland. Tel.: +48 012 430 52 66;
ax: +48 012 430 52 03.
E-mail address: jaanraf@interia.pl (R. Januszek).
914-5087/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2013.12.002anese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Endothelial dysfunction
The endothelium plays a crucial role in vascular homeosta-
sis, described as a balance between arterial diastole and systole.
Endogenous NO is found to be the strongest vasodilator, and a
crucial marker of endothelial function. Endothelial dysfunction is
associated with decreased NO bioavailability, and the subsequent
inability to induce vasodilation [3]. In effect the endothelium may
express pro-inﬂammatory and pro-thrombotic features, activate
oxidative reactions, and stimulate a proliferative state [4].
Most atherosclerosis risk factors such as hypertension, dys-
lipidemia, diabetes, smoking, obesity, or aging contribute to
endothelial dysfunction. However, the pathogenesis of endothelial
dysfunction is complex. The main cellular mechanism leading to
this impairment is oxidative stress, which contributes to a decrease
in ﬂow-mediated dilatation (FMD) values in patients with PAD
[5]. The oxidative modiﬁcation of low-density lipoproteins (LDL)
to ox-LDL (oxygenated low-density lipoproteins) is an important
vier Ltd. All rights reserved.
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tep in the endothelial pathogenesis linked to the development of
therosclerosis. Moreover, LDL and ox-LDL inhibit endothelial NO
ynthase (eNOS) activity [6]. Signiﬁcant endothelial dysfunction,
ften many years worth, must take place before any symptoms or
linical complications arise [7]. Endothelial dysfunction is typically
resent from the earliest stages of atherosclerotic plaque devel-
pment and could be, at least partly reversible at any time. The
unction and general health of the endothelium is inﬂuenced by
arious factors such asmedications, diet, andphysical activity [8,9].
s a measure of endothelial function the FMD value could be used
o differentiate between patients more and less susceptible to the
evelopment and progression of atherosclerotic plaques, despite
edical intervention. According to our knowledge, this is the ﬁrst
tudy with follow-up period after exercise training program, and
MD assessment.
nﬂammation
The inﬂammatory process plays a key role in the pathogene-
is of endothelial dysfunction. High sensitivity C-reactive protein
hs-CRP) is the principal marker of a pro-inﬂammatory state. The
ncreased serum concentration of CRP in patients with atheroscle-
osis as such reﬂects the signiﬁcance of the role of inﬂammation in
he development of plaques [10]. CRP is mostly produced by liver,
ut also by vascular smooth muscle cells and epithelial cells [11].
Ridker et al. proved that elevated CRP in apparently healthy
en predicts the future risk of symptomatic PAD development
12]. Several studies indicate that increased hs-CRP concentration
n healthy people increases the risk of cardiovascular events and
verall mortality rate by 1.5–2% [13]. According to the American
eart Association, hs-CRP concentrations are currently used in clin-
cal practice to classify mild (<1mg/l), moderate (1–3mg/l), and
evere (>3mg/l) risk of cardiovascular events [14].
readmill training
Supervised walking programs are considered to be the most
ffective option to improve asymptomatic walking distance in
atients with claudication [15]. The Intersociety Consensus for the
anagement of PAD (TASC II) states that the optimal intensity of
xercise is that, which is sufﬁcient to reproduce claudication pain
onsidered to be moderate [1]. The safest and most effective train-
ng option in symptomatic PAD patients appears to be pain-free
readmill training interrupted at the onset of moderate pain [16].
ccording to our knowledge, the long-term effects of exercise on
alking capacity have not been reported widely. This study aims
o estimate the short- and long-term effects of treadmill training
n endothelial function and walking capacity in patients with PAD.
ethods
tudy population
Patients with symptomatic PAD (i.e. intermittent claudication)
ged 48–80 years, all in Fontaine stage 2 were recruited from the
ngiology outpatient clinic. The diagnosis of PAD was conﬁrmed by
oppler ultrasound or arteriography and an ankle/brachial index
ABI) of less than 0.9 at rest. All patients had a stable asymptomatic
alking distance and were able to achieve 150m without pain.
he claudication distance was ﬁxed by minimum six months pre-
eding enrollment in the program. We excluded patients with a
istory of unstable angina, recent myocardial infarction, vascular
urgery within the previous year, impaired cardiac or lung func-
ion, cancer, and kidney and liver disease. Furthermore, patients
ho were unable to walk on the treadmill at a speed of at leastiology 64 (2014) 145–151
3.2 km/h were also excluded. All patients had been treated phar-
macologically with a stable regimen, which remained unchanged
6 months before enrollment, throughout the study and during
follow-up. None of the participants were medicated with pento-
xifylline, cilostazol, or selective cyclo-oxygenase-2 inhibitors. This
study complies with the Declaration of Helsinki. All subjects pro-
videdwritten and informed consent before the investigationbegan.
Study protocol was approved by the local ethical committee.
Study design
All patients were evaluated at baseline, after 12 weeks of super-
vised treadmill training, and after a mean follow-up period of 37
weeks by qualiﬁed medical staff.
During each evaluation period we measured maximal walking
time (MWT) during a treadmill test, endothelial function, blood
pressure, and smoking status. Neither the supervised, nor the unsu-
pervised exercise programwasperformedduring follow-upperiod.
Patients underwent regular physical activity. Additionally ABI and
blood analysis was performed before and after the treadmill pro-
gram.
Exercise training
Theexerciseprogramconsistedof 12weeksof supervised, inter-
mittent treadmill walking. Exercise sessions were conducted three
times a week. During each exercise session, treadmill walking was
at speed of 3.2 km/h and the grade individually determined for each
patient that would induce claudication within 3–5min [1]. The
exercise was interrupted when the patient stopped at the onset
of claudication. The severity of claudication pain experienced by
the patient was determined on a scale, where 1=no pain, 2 =onset
of claudication, 3 =mild pain, 4 =moderate pain, and 5=maximal
pain [17]. After exercise, the patient rested until claudication had
abated and then walking was resumed. This cycle of intermittent
walking exercise was applied for 35min at the start of the program
with progressive increase of session time by 5min per 2 weeks.
At subsequent visits, the grade of the treadmill was increased, if
the patient was able to walk for 8min or longer at the previous
workload [9].
Treadmill testing
Walking abilities (MWT) were assessed during morning hours
according to the graded treadmill protocol [18]. Subjects walked
on the treadmill (Gait Trainer, Biodex, Shirley, NY, USA) at an ini-
tial workload of 3.2 km/h, 0% grade for 2min. Subsequent stages
increased 2% in grade every 2min. The speed was set constant
(3.2 km/h) throughout the test. The MWT was recorded when the
patient refused to continue the test because of severe claudication
pain (level 5 on pain scale) [17]. Patients were instructed not to use
handrail support during the treadmill test. The treadmill was cali-
brated prior to each testing. The test was repeated on the next day
and the best of two measurements were used in data analysis.
Endothelial function assessment
The FMD of the brachial artery was assessed using a high reso-
lution echo-Doppler ultrasound (Sequoia 512, Acuson, linear probe
7MHz; Siemens, Erlangen, Germany). The examination was per-
formed in a quiet, temperature-controlled room (23,0–24,0 ◦C)
after a 15-min resting period. The subjects reported to the labo-
ratory between 07.00 and 08.00h after overnight fasting. Patients
were instructed to refrain from physical exercises, caffeine bev-
erages, and tobacco use for 12h prior the test. All temporary
medications were withheld for 24h before testing. The subject was
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in pre-exercise FMD (4.34±2.37% vs. 6.15±2.4%, p<0.001) as well
as post-exercise FMD (4.38±2.29% vs. 6.26±2.62%, p<0.001).
After follow-up the pre-exercise (4.34±2.37% vs. 4.74±2.66%,
Table 1
Baseline group characteristics.
Overall group (n=67)
Male:female 41:26
Age (years) 65.5±7.7
Smoking, n (%) 36 (53.73)
Smoking (years) 34.33±12.63
Cigarettes/day 21±11.2
Peripheral artery disease
Claudication (years) 8.99±6.47
Previous endovascular intervention of peripheral
arteries, n (%)
19 (28.35)
Previous bypass grafting surgery, n (%) 4 (5.97)
Associated diseases, n (%)
Coronary artery disease 22 (32.83)
Previous myocardial infarction 3 (4.47)
Previous endovascular intervention of coronary
arteries
3 (4.47)
Previous coronary artery bypass grafting surgery 2 (2.98)
Hypertension, n (%) 55 (82.08)
Diabetes, n (%) 14 (20.89)
Chronic obstructive pulmonary disease/bronchial
asthma
7 (10.44)
Treatment, n (%)
Aspirin 64 (95.52)
Clopidogrel/ticlopidine 12 (17.91)
Statins/ﬁbrates/ezetimibe 67 (100)
Angiotensin-converting enzyme
inhibitors/aldosterone receptors blockers
39 (58.2)
Calcium channel blockers 22 (32.83)
Beta-blockers 34 (50.74)
Diuretics 19 (28.35)
Values are mean± SD and percentages (in parentheses) when appropriate.
Table 2
Location of the lower limb artery lesions in patients who completed the training
program.
The types of lesion, n (%) Location Cases, n (%)
Total, 67 (100) Crural artery 33 (49.25)
Popliteal artery 16 (23.88)
Femoral artery 43 (64.17)
Iliac artery 7 (10.44)
Single segmental, 21
(31.34)
Crural artery 4 (19.04)
Popliteal artery 3 (14.28)
Femoral artery 12 (57.14)
Iliac artery 2 (9.52)
Two segmental, 29
(43.28)
Popliteal–crural artery 4 (13.79)
Femoral–crural artery 19 (65.51)
Femoral–popliteal artery 1 (3.44)
Iliac–femoral artery 5 (17.24)R. Januszek et al. / Journal o
ositioned supine with the arm ﬁxed in a comfortable position
or imaging the brachial artery 2 cm above the antecubital fossa
n the longitudinal plane. A segment with clear anterior and pos-
erior intimal interfaces between the lumen and vessel wall was
elected for imaging [19]. The imageswere recorded for 30 s at rest.
hereafter, arterial occlusion was produced with the pneumatic
phygmomanometric cuff placed below the antecubital fossa and
nﬂated 50mmHg over the systolic blood pressure. After 5min of
schemia, the cuff was deﬂated. The diameter of the brachial artery
as measured for 60–90 s after deﬂation. The mean of 3 maximal
nd-diastolic diameter measurements was assumed to calculate
MD value. The percent change in artery diameter during post-
cclusive reactive hyperemia was taken as the value of FMD [20].
he measurement was performed at rest and repeated 15min after
he treadmill test to maximal claudication pain. The measurement
as made by blinded, trained, and experienced medical staff.
iochemical analyses
Blood samples were collected the day following a training
ession after an overnight fast. Patients were asked to refrain from
moking 12h prior to the blood test. Blood samples for the analy-
is of ﬁbrinogen, high-sensitivity C-reactive protein (hs-CRP) and
ipid proﬁle: total cholesterol, high-density lipoprotein cholesterol
HDL-C), low-density lipoprotein cholesterol (LDL-C), and trigly-
erides, were drawn from the forearm vein (between 09.00h and
0.00h) after 30min rest and immediately sent to the laboratory.
ther measures
To calculate the ABI, we measured blood pressure in the upper
nd lower limbs.We used continuouswaveDoppler detector in the
ase of the lower limbs, and for the upper limbs regular sphygmo-
anometer. Measurements were performed on the brachial artery
n the upper limbs and the posterior tibial and dorsalis pedis artery
n the lower limbs. In the case of different pressures in the same
imb we took into account the higher value. ABI was calculated
s the ratio of systolic blood pressure in the foot to systolic blood
ressure in the arm[1]. Smoking statuswasdeterminedas the aver-
ge number of cigarettes smoked daily and the number of years
moked, height and weight were measured before and after the
rogram, and body mass index (BMI) was calculated.
tatistical analysis
Changes in variables over 12 weeks of the training program
nd the follow-up period were analyzed by Wilcoxon signed-
ank test and ANOVA. The Spearman rank correlation coefﬁcients
ere used to assess the possible relationship between variables.
he statistical analyses were performed using Statistica 10.0 soft-
are (http://statistica.software.informer.com/10.0/). The data are
xpressed as means, SD, medians, and interquartile range (IQR)
hen appropriate. Statistical signiﬁcance was accepted at a 0.05
evel of probability.
esults
Fromamong85enlistedparticipants, 67completed the12-week
raining program. The mean duration of follow-up was 37 weeks
min. 16 weeks, max. 54 weeks). Of the 67 patients who completed
raining, 27 were lost to follow-up (18 lack of desire to continue
he research, 2 urgent abdominal surgery, 1 coronary artery disease
xacerbation, 2 arrhythmias, 2 orthopedic diseases, 1 obstructive
ulmonary disease exacerbation, 1 urgent deterioration of PAD
ymptoms and following angioplasty), and 40 completed the entire
tudy. The clinical characteristics of the 67 patientswho completediology 64 (2014) 145–151 147
the 12-week program is presented in Table 1. The distribution of
culprit lesions of lower limb arteries is presented in Table 2.
After the exercise program we observed an insigniﬁcant
increase in LDL, HDL, TG, and total cholesterol, whereas serum
ﬁbrinogen slightly decreased (4.39±1.52g/l vs. 4.28±1.18g/l,
p=0.33). We observed a drop in hs-CRP concentration
(3.33±4.07mg/l vs. 2.54±2.51mg/l, p=0.025) and an increase
in ABI (0.63±0.17 vs. 0.66±0.18, p=0.039) (Table 3). However,
after follow-up ABI value decreased signiﬁcantly compared to that
after exercise program (0.66±0.18 vs. 0.65±0.16, p=0.015), and
became insigniﬁcantly higher compared to entry value (p=0.89).
After 12 weeks, the exercise program resulted in a signiﬁcant riseThree or more
segments, 6 (8.95)
Femoral–popliteal–crural artery 4 (66.67)
Iliac–femoral–crural artery 1 (16.67)
Iliac–femoral–popliteal artery 0 (0)
Iliac–femoral–popliteal–crural artery 1 (16.67)
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Table 3
Changes in biochemical variables, BMI, and ABI after training program.
Variables Baseline Week 12 p
Total-cholesterol (mmol/l) 4.65±1.08
4.4 [3.9–5.3]
4.74±1.07
4.6 [4.0–5.3]
0.45
LDL-cholesterol (mmol/l) 2.49±1.05
2.29 [1.75–3.06]
2.52±1.05
2.32 [1.9–2.91]
0.98
HDL-cholesterol (mmol/l) 1.35±0.29
1.35 [1.1–1.5]
1.36±0.27
1.3 [1.2–1.5]
0.47
Triglycerides (mmol/l) 1.77±0.98
1.42 [1.1–2.18]
1.88±1.13
1.62 [1.14–2.24]
0.39
hs-CRP (mg/l) 3.33±4.07
2.225 [1.08–3.87]
2.54±2.51
1.46 [0.79–3.3]
0.025
Fibrinogen (g/l) 4.39±1.52
4.25 [3.4–5.22]
4.28±1.18
4.2 [3.4–5.0]
0.33
BMI (kg/m2) 26.3±3.6
26.32 [23.74–28.32]
25.97±3.42
25.76 [23.8–27.72]
0.38
ABI 0.63±0.17
0.66 [0.5–0.76]
0.66±0.18
0.675 [0.52–0.79]
0.039
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between the extent of improvement of FMD and smoking quantityean value± standard deviation; median [lower–upper quartile]; the Wilcoxon sig
-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
= 0.74) and post-exercise (4.38±2.29% to 5.68±3.02%, p=0.058)
MD declined and remained elevated compared to baseline,
lbeit insigniﬁcantly. The drop of pre- and post-exercise FMD
alues after follow-up period, in comparison to measurements
erformed after exercise program was not signiﬁcant (p=0.13,
= 0.49). There was no statistically signiﬁcant difference between
re- and post-exercise FMD, however post-exercise values were
onsistently higher, especially at the end of follow-up (p=0.09)
Fig. 1). The baseline brachial artery diameter did not differ
igniﬁcantly between pre- and post-exercise measurement at
ach time point (4.44±0.65mm vs. 4.38±0.63mm, p=0.31;
.42±0.58mm vs. 4.42±0.55mm, p=0.99; 4.6±0.61mm vs.
.6±0.63mm, p=0.91). There was also no signiﬁcant difference in
aseline brachial artery diameter between following time points in
re- and post-exercise values. In the clinical picture, a signiﬁcant
mprovement in exercise tolerance, assessed by the maximal walk-
ng time (MWT) was observed after training (470.81±187.11 s
ig. 1. Themaximalwalking timeatbaseline, after12weeksof the treadmill training
nd after follow-up period. The Wilcoxon signed-rank test, *ANOVA. FMD, ﬂow-
ediated dilatation.ank test; ABI, ankle/brachial index; BMI, body mass index; hs-CRP, high sensitivity
vs. 898±358.72 s, p<0.001). Likewise, after follow-up the MWT
decreased signiﬁcantly (p<0.001, in comparison to measurements
made after exercise program); however, maintained a signiﬁcant
improvement in comparison to baseline (470.81±187.11 s vs.
775.36±345.37 s, p<0.001) (Fig. 2). Neither the smoking status
nor the BMI changed signiﬁcantly (p>0.05).
Nosigniﬁcant correlationbetween theFMD,MWT(Figs. 3and4),
BMI, ABI, biochemical measurements, smoking status, duration
of PAD, and/or age was noticed at baseline, after exercise pro-
gram, and follow-up period. Interestingly, even the improvement
in FMD (FMD) after 12 weeks of exercise program and follow-up
period did not correlate with improvement of MWT (MWT) and
BMI value (ABI), respectively. We noticed a negative correlation(pack years) (p<0.05).
Fig. 2. The rest and post-exercise ﬂow-mediated dilatation values at baseline, after
12 weeks of the treadmill training and after follow-up period. The Wilcoxon signed-
rank test, *ANOVA.
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aig. 3. Correlation between ﬂow-mediated dilatation and maximal walking time
efore exercise program (r=−0.1, p=0.43, CI = 95%).
iscussion
alking abilities
This supervised exercise program proved efﬁcacious in enhanc-
ng the patients’ exercise tolerance. We observed a signiﬁcant
mprovement in MWT after training and follow-up in comparison
o baseline. This improvement in walking abilities was comparable
o that reported in so far published studies [19]. However, pub-
ications with long-term observations and follow-up of walking
bility are limited. Keo et al. noticed a signiﬁcant improvement of
aximal walking distance (MWD) after a 12-week training pro-
ram in patients with PAD, which persisted as a signiﬁcant clinical
mprovement for 39 months of follow-up [21]. Moreover, Perkins
t al. demonstrated that the long-term impact of treadmill training
nMWDinpatientswith PAD is comparable topercutaneous trans-
uminal angioplasty (PTA) after approximately 6 years of follow-up.
he effectiveness of supervised treadmill training dependedmostly
n the location of the occluded artery [22]. However, in our study,
he population was not evaluated in this respect. Undoubtedly,
ntensity and typeofphysical activityduring follow-upperiodplays
crucial role in sustaining MWT. It is difﬁcult to assess accurately
he extent of homeexercise anddifferentiate it objectively between
atients. The impact of unsupervised exercise programs on
ig. 4. Correlation between ﬂow-mediated dilatation and maximal walking time
fter follow-up period (r=0.07, p=0.66, CI = 95%).iology 64 (2014) 145–151 149
walking abilities during follow-up period has not been clearly
deﬁned so far. Additionally, we lost 27 of 67 patients (40%), dur-
ing the follow-upperiodwhich could inﬂuenceﬁnal results, despite
the fact thatmost of the patients refused follow-up visitmost likely
due to lack of further beneﬁt.
As in our ﬁndings, non-smokers seemed to beneﬁt more than
smokers from an exercise regimen [21]. Similar results were
obtained by Rossini et al. after 4 weeks of supervised training and
one year follow-up in patients with moderate-to-severe claudi-
cation [23]. We did not observe a signiﬁcant difference in MWT
and FMD after the training program in comparison to follow-up
between smokers and non-smokers, however the lack of sustained
beneﬁts to MWT at follow-up was slightly, although not signiﬁ-
cantly smaller in non-smokers than in smokers.
Endothelial function
Interestingly, although not surprisingly, we observed a signif-
icant improvement in FMD after a treadmill training program.
At follow-up, the improvement in FMD values was maintained,
although without statistical signiﬁcance. Impaired endothelial
function, associatedwithhigh levelsofCRPandﬁbrinogen,hasbeen
demonstrated in patients with PAD [23]. Possible acute endothelial
injury, induced by repeated training sessions did not inﬂuence sig-
niﬁcant change in pre- and post-exercise FMD at each time point.
Preliminary studies suggest that restoration of normal endothelial
function is coupled with a reduction in cardiovascular events, as
well as the improvement in walking abilities in patients with clau-
dication [2]. Although the beneﬁcial effects of exercise training on
endothelial function have been reported previously, the impact of
exercise during follow-up period is still insufﬁciently investigated
[24]. It was postulated, that systemic effects of physical activity
may have an impact on endothelial function [25]. The mechanism
of such an improvement was generally attributed to the enhanced
endothelial synthesis of NO, which is stimulated by an increase
in blood ﬂow [26]. Improvement in blood ﬂow could be due to
collateralization, which has been suggested in patients with coro-
nary artery disease after exercise training [27]. Conﬁrmation of
this thesis is justiﬁed by a signiﬁcant improvement in ABI at the
end of the program, which is closely associated with an increase
in blood ﬂow. However, after the training program and follow-up,
we did not observe correlation between the change in FMD and
ABI. Another mechanism explaining an improvement in endothe-
lial function could be associated with altered lipoprotein levels
[28]. Albeit, we did not observe signiﬁcant changes in lipid pro-
ﬁle in our study, with increased tendency. This could be explained
by a relatively small effect of physical activity on lipid proﬁle in
comparison to statin therapy and a short period of study. The pos-
itive systemic effects of exercise on endothelial function, could be
partly explained by a decline in the inﬂammatory response (rep-
resented by a decrease in pro-inﬂammatory markers hs-CRP, etc.),
which was observed in our research. Additionally, risk factors such
as gender, obesity, concomitant diseases could modify the effect
of physical activity on FMD. The improvement in endothelial func-
tion after exercise training with tendency to be maintained at a
high level during follow-up period in comparison to baseline val-
ues, could suggest that the endothelial changes induced during
the 12-week exercise training, altered its function for almost 10
months on average, even after the cessation of physical activity. It
is difﬁcult to compare our results to other studies, because there
is limited research done in this area, particularly those with FMD
measurementduring follow-up.Weexplain thisbyspeculating that
exercise may induce a change in the genetic expression and hence
production of particular proteins involved with the improvement
in endothelial function, on a translational and transcriptional level
which is maintained for months.
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nﬂammation
Treadmill training is both a safe and cheap therapeutic approach
nd importantly in further observation does not escalate the
nﬂammatory process in patients with claudication [29]. Elevated
evels of CRP and ﬁbrinogen, initially observed prior to commenc-
ng training, signiﬁcantly declined after 3 months, yet only CRP
emained signiﬁcantly lower at follow-up. This may prove to be
nough though, as CRP is an important prognostic indicator of
uture cardiovascular events in persons both with and without
therosclerosis [14]. According to the American Heart Association
uidelines, a decline inmeanCRP concentration reduces the overall
isk of cardiovascular disease from high to moderate [14].
Andreozzi et al. suggested that moderate hemodynamic stress
educes the level of pro-inﬂammatory markers and improves FMD
hrough ischemic preconditioning [20]. Based on our ﬁndings, an
ncrease in FMD after treadmill training was accompanied by a
ecrease in hs-CRP. These parameters, taken as intriguing yet
ensible representations of endothelial function and endothelial
nﬂammation could, at least in part, explain the systemic effects
f treadmill training as a reduction in the inﬂammatory response
eading to an appropriate improvement in endothelial function.
n the contrary, Saxton et al. reported only a tendency, without
tatistical signiﬁcance for 24 weeks of upper and lower limb exer-
ise to reduce hs-CRP [30]. The inﬂuence of exercise training on
brinogen in patientswith claudication is not clear. Some scientists
bserved signiﬁcant rise in ﬁbrinogen level after physical training,
hereas others did not [31,32]. The decline in pro-inﬂammatory
arkers did not correlate well with changes in lipid proﬁle. Our
esults as well as those of previous studies indicate that exer-
ise tends to decrease rather than increase the pro-inﬂammatory
arkers [19].
tudy limitations
The limitation of our study is the lack of a ‘no-training’ control
roup and a ‘healthy’ training control group, aswell as the potential
onfounding variables of patient medication usage or the endothe-
ium’s adaptation tolerance to exercise. We could not control total
aily physical activity, which to begin with is quite limited in this
atient subset and undoubtedly differed between all participants.
hese could have had a positively and negatively distorting impact
n the ﬁnal results.
onclusions
In conclusion, based on the improvement in both endothelial
unction and walking tolerance after a training program, the efﬁ-
acy of supervised exercise training seems to be irrefutable. The
ecline in pro-inﬂammatory markers reduced the risk of future
ardiovascular events. A 12-week trainingprogram induces perma-
ent changes in the peripheral vascularization, and improvement
n FMD and walking indices, even after cessation of supervised and
egular exercise. We also conclude that lipid proﬁle is not affected
y supervised and repetitive exercise. The effect of an unsupervised
xercise program, particularly after a supervised exercise program
eeds to be further diagnosed and observed.onﬂict of interest
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